Alterations in l-arginine and inflammatory markers in type 2 diabetic patients with and without microalbuminuria

被引:20
作者
Baris, Necla [1 ]
Erdogan, Mehmet [2 ]
Sezer, Ebru [1 ]
Saygili, Fuesun [2 ]
Ozgonul, A. Mert [1 ]
Turgan, Nevbahar [1 ]
Ersoz, Biltan [1 ]
机构
[1] Ege Univ, Sch Med, Dept Biochem, Izmir, Turkey
[2] Ege Univ, Sch Med, Dept Endocrinol, Izmir, Turkey
关键词
Microalbuminuria; Neopterin; L-Arginine; Hs-CRP; Endothelial function; Cardiovascular risk; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; NEOPTERIN; GLYCATION; GLUCOSE; SERUM; RISK;
D O I
10.1007/s00592-008-0089-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Low-grade inflammation is closely involved in the pathogenesis of type 2 diabetes and associated micro- and macrovascular complications. The nitric oxide (NO) precursor l-arginine, is relevant to diverse pathological conditions including type 2 diabetes and its complications. High sensitive-CRP (hs-CRP), neopterin and arginine levels were measured in 46 normoalbuminuric, 45 microalbuminuric type 2 diabetics and in 32 healthy controls in order to assess the relationship between markers of inflammation and l-arginine. Hs-CRP concentrations were higher in microalbuminuric diabetic patients compared to normoalbuminuric patients and controls. Diabetics had higher serum and urine neopterin levels than controls. Urine neopterin and l-arginine levels differed significantly among diabetic patients with and without microalbuminuria. There were significant positive correlations between hs-CRP and BMI in healthy controls and diabetics with and without microalbuminuria. In microalbuminuric diabetics, hs-CRP correlated with microalbuminuria (MAU). Significant predictors for the development of microalbuminuria were higher postprandial glucose levels, lower creatinine clearance and lower serum l-arginine levels. Assessment of early markers of inflammation and endothelial function, such as neopterin and NO precursor l-arginine, may help to predict incipient nephropathy more accurately in type 2 diabetic patients.
引用
收藏
页码:309 / 316
页数:8
相关论文
共 29 条
[1]   Plasma leptin concentration in patients with Type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance [J].
Abdella, NA ;
Mojiminiyi, OA ;
Moussa, MA ;
Zaki, M ;
Al Mohammedi, H ;
Al Ozairi, ESS ;
Al Jebely, S .
DIABETIC MEDICINE, 2005, 22 (03) :278-285
[2]   DETERMINATION OF AMINO-ACID PROFILES IN BIOLOGICAL SAMPLES BY GAS-CHROMATOGRAPHY [J].
ADAMS, RF .
JOURNAL OF CHROMATOGRAPHY, 1974, 95 (02) :189-212
[3]   Standards of medical care in diabetes 2008 [J].
不详 .
DIABETES CARE, 2008, 31 :S12-S54
[4]   Increased plasma endothelin-1 and intraplatelet cyclic guanosine monophosphate in men with disturbed glucose metabolism [J].
Anwaar, I ;
Gottsäter, A ;
Eriksson, KF ;
Jacobsson, L ;
Lindgärde, F ;
Mattiasson, I .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2000, 50 (02) :127-136
[5]   Association between fasting glucose and C-reactive protein in middle-aged subjects [J].
Aronson, D ;
Bartha, P ;
Zinder, O ;
Kerner, A ;
Shitman, E ;
Markiewicz, W ;
Brook, GJ ;
Levy, Y .
DIABETIC MEDICINE, 2004, 21 (01) :39-44
[6]   Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation - Effects of short- and long-term simvastatin treatment [J].
Ceriello, A ;
Taboga, C ;
Tonutti, L ;
Quagliaro, L ;
Piconi, L ;
Bais, B ;
Da Ros, R ;
Motz, E .
CIRCULATION, 2002, 106 (10) :1211-1218
[7]   L-Arginine transporters in cardiovascular disease: A novel therapeutic target [J].
Chin-Dusting, J. P. F. ;
Willems, L. ;
Kaye, D. M. .
PHARMACOLOGY & THERAPEUTICS, 2007, 116 (03) :428-436
[8]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[9]  
FRASER DJ, 2007, MEDICINE, V35, P503
[10]   Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy [J].
Friedman, AN ;
Hunsicker, LG ;
Selhub, J ;
Bostom, AG .
ATHEROSCLEROSIS, 2004, 172 (01) :121-125